Literature DB >> 20134487

Liver: Management of non-acetaminophen-induced ALF.

Stephen M Riordan, Roger Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20134487     DOI： 10.1038/nrgastro.2009.236

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Green tea extracts and acute liver failure: the need for caution in their use and diagnostic assessment.

Authors:  Manuel Jimenez-Saenz; Carmen Martinez-Sanchez
Journal:  Liver Transpl       Date:  2007-07       Impact factor: 5.799

2.  The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.

Authors:  T S Walsh; P Hopton; B J Philips; S J Mackenzie; A Lee
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

Authors:  P M Harrison; R Keays; G P Bray; G J Alexander; R Williams
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

4.  Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.

Authors:  Neil C Henderson; Katharine J Pollock; John Frew; Alison C Mackinnon; Richard A Flavell; Roger J Davis; Tariq Sethi; Kenneth J Simpson
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

5.  Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure.

Authors:  Christine Kortsalioudaki; Rachel M Taylor; Paul Cheeseman; Sanjay Bansal; Giorgina Mieli-Vergani; Anil Dhawan
Journal:  Liver Transpl       Date:  2008-01       Impact factor: 5.799

6.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.

Authors:  R Keays; P M Harrison; J A Wendon; A Forbes; C Gove; G J Alexander; R Williams
Journal:  BMJ       Date:  1991-10-26

7.  Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.

Authors:  P M Harrison; J A Wendon; A E Gimson; G J Alexander; R Williams
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

8.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.

Authors:  William M Lee; Linda S Hynan; Lorenzo Rossaro; Robert J Fontana; R Todd Stravitz; Anne M Larson; Timothy J Davern; Natalie G Murray; Timothy McCashland; Joan S Reisch; Patricia R Robuck
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

9.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.

Authors:  L F Prescott; R N Illingworth; J A Critchley; M J Stewart; R D Adam; A T Proudfoot
Journal:  Br Med J       Date:  1979-11-03

10.  Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity.

Authors:  Runkuan Yang; Keita Miki; Xin He; Meaghan E Killeen; Mitchell P Fink
Journal:  Crit Care       Date:  2009-04-09       Impact factor: 9.097
  10 in total
  1 in total

1.  SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages.

Authors:  Jia Yu; Lili Liu; Huiming Zhang; Yating Wu; Heying Pei; Liang Ma; Anwen Xiong; Caifeng Xie
Journal:  RSC Adv       Date:  2018-09-27       Impact factor: 3.361
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.